relief 20 mg daily dose paroxetine paxil eli lilly makes attempt fda approval duloxetine fda asks company clinical trials fda recommends approval duloxetine violations eli lilly indianapolis plant drug manufactured agency cites potential liver toxicity fda reviews liver health data approves duloxetine depression diabetic neuropathy pain based set clinical trials serotonin norepinephrine stifle pain signals traveling brain rest body cymbalta continues studied treatment mood pain disorders cymbalta goes patent end year july eli lilly expected lay 1,000 sales workers anticipation revenue loss cymbalta osteoporosis drug evista bring $ 5 billion annually eli lilly evista goes patent early 2014 article originally